Cocrystal Pharma Inc

CUSIP 19188J409COM NEWCOCPQ1 2026

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

17.8%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

4 filings · latest Oct 30, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Oct 30, 2025	Phillip Frost, M.D.	13D/A	17.8%	—	SEC
2	Oct 2, 2025	Phillip Frost, M.D.	13D/A	10.6%	—	SEC
3	Apr 14, 2023	Frost Phillip Md Et Al	13D/A	13.1%	1.33M	SEC
4	Apr 12, 2023	Hassan Fred	13G	10.0%	1.02M	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Renaissance Technologies LLC	123.9K	$125.2K
2	Geode Capital Management, LLC	90.2K	$91.1K
3	Blackrock, Inc.	73.7K	$74.5K
4	T3 Companies, LLC	51.5K	$52.0K
5	Xtx Topco Ltd	36.0K	$36.4K
6	Neuberger Berman Group LLC	31.9K	$32.2K
7	State Street Corp	20.5K	$20.7K
8	Two Sigma Securities, LLC	15.3K	$15.4K
9	Jane Street Group, LLC	12.7K	$12.8K
10	Parallel Advisors, LLC	12.6K	$12.7K